Microdosing

Taking a fraction of a standard dose, usually more frequently, in the hope of retaining benefit while reducing side effects.

In plain terms

Widely discussed for GLP-1 drugs. It is a hypothesis, not a protocol: the approved dosing schedules were the ones tested, and the outcomes attributed to these drugs were produced at those doses. Microdosing may well reduce side effects. Whether it preserves the benefits is not established.

Guides that use this term

Microdosing GLP-1s: what is actually known

Microdosing semaglutide or tirzepatide is widely discussed and has never been tested in a randomised trial. Here is what exists, what does not, and why the distinction matters.

Educational reference only. Pepperz does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing recommendations.